Cornelia Kamp
Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Evidence-Based Medicine | 2 | 2009 | 125 |
Why?
|
Clinical Trials as Topic | 3 | 2009 | 251 |
Why?
|
Pain | 2 | 2009 | 191 |
Why?
|
Levodopa | 2 | 2004 | 28 |
Why?
|
Parkinson Disease | 3 | 2004 | 67 |
Why?
|
Benzothiazoles | 2 | 2004 | 22 |
Why?
|
Research Subjects | 1 | 2009 | 11 |
Why?
|
Analgesics | 1 | 2010 | 47 |
Why?
|
Comprehension | 1 | 2009 | 27 |
Why?
|
Pain Measurement | 1 | 2010 | 98 |
Why?
|
Oxycodone | 1 | 2009 | 8 |
Why?
|
Delayed-Action Preparations | 1 | 2009 | 31 |
Why?
|
Informed Consent | 1 | 2009 | 62 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2009 | 24 |
Why?
|
Amines | 1 | 2009 | 39 |
Why?
|
Herpes Zoster | 1 | 2009 | 17 |
Why?
|
Outcome Assessment (Health Care) | 1 | 2010 | 163 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2009 | 58 |
Why?
|
Akathisia, Drug-Induced | 1 | 2007 | 8 |
Why?
|
Antiparkinson Agents | 1 | 2007 | 23 |
Why?
|
Thiazoles | 1 | 2004 | 50 |
Why?
|
Treatment Outcome | 3 | 2009 | 661 |
Why?
|
Aged | 5 | 1995 | 988 |
Why?
|
Myositis | 1 | 1995 | 14 |
Why?
|
Myopathies, Nemaline | 1 | 1993 | 2 |
Why?
|
Inclusion Bodies | 1 | 1993 | 20 |
Why?
|
Double-Blind Method | 2 | 2004 | 274 |
Why?
|
Muscles | 1 | 1993 | 111 |
Why?
|
Male | 6 | 1993 | 1553 |
Why?
|
Follow-Up Studies | 2 | 2004 | 553 |
Why?
|
Female | 6 | 1993 | 1643 |
Why?
|
Middle Aged | 4 | 1995 | 1161 |
Why?
|
Muscle, Skeletal | 1 | 1995 | 114 |
Why?
|
Cell Nucleus | 1 | 1993 | 169 |
Why?
|
Humans | 7 | 1993 | 1856 |
Why?
|
Ubiquinone | 1 | 2009 | 11 |
Why?
|
Medication Adherence | 1 | 2009 | 19 |
Why?
|
Vitamins | 1 | 2009 | 30 |
Why?
|
Texas | 1 | 2009 | 21 |
Why?
|
Placebo Effect | 1 | 2009 | 26 |
Why?
|
Aging | 1 | 1995 | 275 |
Why?
|
Chronic Disease | 1 | 2010 | 267 |
Why?
|
Analgesics, Opioid | 1 | 2009 | 37 |
Why?
|
Cognition | 1 | 2009 | 97 |
Why?
|
Acute Disease | 1 | 2009 | 271 |
Why?
|
Cross-Sectional Studies | 1 | 2009 | 253 |
Why?
|
Probability | 1 | 2007 | 190 |
Why?
|
New York | 1 | 2009 | 422 |
Why?
|
Questionnaires | 1 | 2009 | 360 |
Why?
|
Proportional Hazards Models | 1 | 2004 | 123 |
Why?
|
Adult | 3 | 1993 | 1317 |
Why?
|
Quality of Life | 1 | 2004 | 188 |
Why?
|
Severity of Illness Index | 1 | 2004 | 358 |
Why?
|
Succinate Dehydrogenase | 1 | 1995 | 14 |
Why?
|
Polymyositis | 1 | 1995 | 8 |
Why?
|
Mitochondria, Muscle | 1 | 1995 | 10 |
Why?
|
Dermatomyositis | 1 | 1995 | 16 |
Why?
|
Biopsy | 1 | 1995 | 207 |
Why?
|
Microscopy, Electron | 1 | 1993 | 178 |
Why?
|
Immunohistochemistry | 1 | 1993 | 355 |
Why?
|
Infant, Newborn | 1 | 1993 | 389 |
Why?
|
Infant | 1 | 1993 | 464 |
Why?
|
Child | 1 | 1993 | 749 |
Why?
|
Adolescent | 1 | 1993 | 891 |
Why?
|
